Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study. - Wikidata - awgldk - TriplyDB

Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.

Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.

http://www.wikidata.org/entity/Q36635502

about

Glucagon-like Peptide 1 Drugs as Second-line Therapy for Type 2 Diabetes.Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials.Diabetes drugs and the incidence of solid cancers: a survey of the current evidence.Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review.Incretin - based therapy in diabetes mellitus: present scenario and expanding horizons Exenatide modulates tumor-endothelial cell interactions in human ovarian cancer cells.Incretin-based therapies and risk of pancreatic cancer in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.Mir-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.Incretin-Based Therapies: Revisiting Their Mode of Action.Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review.Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

P2860

Q37427165-08F34A04-1310-4209-940E-69D3EAE6401E Q37427294-429866A1-B96F-4AF7-9CF5-6E99035DC782 Q38651175-459267E1-E6C1-4687-A534-22CBCB6F051E Q38858585-0D0B683D-019D-4853-970B-A5BCD82653E1 Q42381260-93839877-D3F5-4AF1-9DD7-40B7D20B893C Q44197738-47D6D1CC-7D6A-4052-BFC8-5A8F80CFC318 Q47386188-88EA7A76-E369-4C07-84C8-CC26F0C3EB8E Q47443146-ABBF715C-F256-4C1A-A949-FF666D025A98 Q47868323-7EF00423-A2BB-4DDD-A8D0-1D156C52BB5F Q48164658-38F33589-6129-49E6-8675-3DC8206C150B Q52343188-BF0BC7FA-A483-478C-93C4-3372AD203019 Q55475796-14A841FA-AE7E-417B-A4A6-19988A724600

P2860

Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.

http://www.wikidata.org/entity/Q36635502

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Incretin based drugs and the r ...... onal multicentre cohort study.

@ast

Incretin based drugs and the r ...... onal multicentre cohort study.

@en

type

label

Incretin based drugs and the r ...... onal multicentre cohort study.

@ast

Incretin based drugs and the r ...... onal multicentre cohort study.

@en

prefLabel

Incretin based drugs and the r ...... onal multicentre cohort study.

@ast

Incretin based drugs and the r ...... onal multicentre cohort study.

@en

P1433

Q36635502-1659D8E3-DDA6-43F4-837A-5FE92C7CB186

P1476

Q36635502-21687C3F-5E02-4015-BBF0-A7D630BF06FD

P2093

Q36635502-06BE221A-3963-40D5-B009-CE0176B41995

Q36635502-5A62FFFB-F97F-4AD7-A71C-A4AF038DF8C2

Q36635502-6FE6DC27-8E5C-463B-83DE-658F292C121C

Q36635502-926932F1-D810-4074-BE6D-FD32BEFB5301

Q36635502-A82BAB53-E184-4925-8CBF-A6E66BA922B8

Q36635502-BA07D14A-FEAA-4CB6-AAD7-E2F6F0611424

Q36635502-BC592577-62FC-46CE-9920-9F8D09D4CAA9

Q36635502-D568D003-10A3-465B-B39D-FED8046F3088

Q36635502-EB60A688-83CA-4A95-ADA4-C96C974731D1

Q36635502-F0AD53DE-789C-4177-BE20-36FCD10BDBEE

P2860

Q36635502-0436B54B-D0D3-47BB-9B2F-E328E552ED24

Q36635502-0595754F-CBCC-40D0-B464-DFEF985D83FD

Q36635502-0B4EABB4-E2E2-4E87-A05C-CDE32BB6B8B6

Q36635502-0C24F9E4-7C0C-4280-85BD-29B26E3A2A04

Q36635502-127E5368-FEAB-446C-8F07-77D49FC66BB9

Q36635502-1A2F1E43-1468-4729-9458-81BC6E1903C8

Q36635502-28DC5CFA-D72C-4C7A-BBFC-EC598BFA4026

Q36635502-3310F68B-4B52-4CC6-BD8C-915548538FB1

Q36635502-4086E063-3F60-4348-92C1-992E20F32D43

Q36635502-45702E0D-191B-489D-8ADD-E35F6126DB66

P304

Q36635502-B91E5C6B-26BD-4D6B-A5BB-4EC3BD830DD4

P31

Q36635502-56AB161D-DC33-495D-9655-791D040F604D

P356

Q36635502-0E29679D-F441-463D-B942-3CE63C330965

P407

Q36635502-DA288BF2-0F2B-47AE-8139-AF98792F9707

P478

Q36635502-86467CA6-EF9D-4848-B06E-BE4946B5754E

P50

Q36635502-AE9D4E9B-354D-4BCB-B5EA-5C185104F83E

Q36635502-E6E648D1-9344-40DA-A15E-570D238F3802

P577

Q36635502-1CC1852B-7C93-4EAE-A1AE-0650825EF079

P5875

Q36635502-A69F1ACE-7B13-4866-9111-19710E2CD9A3

P698

Q36635502-4F51107C-801E-42BC-A860-E17256DBC8EC

P921

Q36635502-355CD58E-3B47-446E-9CED-D01785D216EB

P932

Q36635502-742B1CE3-D50F-4926-9D70-0FFCE78637DB

P356

P1433

P1476

Incretin based drugs and the r ...... onal multicentre cohort study.

@en

P2093

Canadian Network for Observational Drug Effect Studies Investigators

http://www.w3.org/2001/XMLSchema#string

Colin R Dormuth

http://www.w3.org/2001/XMLSchema#string

David N Juurlink

http://www.w3.org/2001/XMLSchema#string

J Michael Paterson

http://www.w3.org/2001/XMLSchema#string

Kristin K Clemens

http://www.w3.org/2001/XMLSchema#string

Laura E Targownik

http://www.w3.org/2001/XMLSchema#string

Laurent Azoulay

http://www.w3.org/2001/XMLSchema#string

Madeleine Durand

http://www.w3.org/2001/XMLSchema#string

Matthew Dahl

http://www.w3.org/2001/XMLSchema#string

Pierre Ernst

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer

Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure

Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study

Metformin and the risk of cancer: time-related biases in observational studies

Meta-analysis in clinical trials

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Pancreatic safety of incretin-based drugs--FDA and EMA assessment

P304

i581

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.I581

http://www.w3.org/2001/XMLSchema#string

P407

P478

352

http://www.w3.org/2001/XMLSchema#string

P50

Tanvir C. Turin

Kristian B Filion

P577

2016-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295255522

http://www.w3.org/2001/XMLSchema#string

P698

26888382

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

4772785

http://www.w3.org/2001/XMLSchema#string